SBIR/STTR Research Award

RAPID, BEDSIDE, LIQUIFICATION OF SOLID DRUGS

Award identifier cacf303fa5c8182ba613861b5dbdf058b95a9aa56eaca2c466a18599b47b2352Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$99,546

Program and phase

SBIR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Engineering Acoustics Incorporated
Proposal award date
Not reported
Contract end date
Not reported
UEI
MJTBFM8ZMS67
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): An estimated 3.75 billion drug administrations were made to patients in United States hospitals in 1998, of which approximately 10% received their medications through an enteral tube as liquids. This number is growing. Despite the availability of a vast drug pharmacopoeia and sophisticated medication distribution system, institutional care givers still liquify capsules and tablets at the bedside for over 55% of the liquid medication needs of their patients. This "extemporaneous compounding of liquid medications" [ECLM] from solid drug forms has significant problems impacting caregiver efficiency, enteral tube failure, and safe and effective administration of [liquid] medications; problems unremedied by pharmaceutical manufacturers, pharmacy intervention, or legacy drug crushing devices. In preliminary studies, we have demonstrated that ultrasound can rapidly and successfully liquify all types of medications appropriate for liquid enteral administration, while avoiding many shortcomings of legacy methods. The approach has considerable potential to decrease costs and improve medication use in acute and long term institutional care settings. In the Phase I effort we propose to build a proof of concept ultrasonic device optimized to liquify solid medications, and examine the processing variables to maximize efficiency and drug stability. The Phase II study would complete the processing variable study, consider methods of direct administration, include comprehensive drug compatibility testing, and incorporate device user requirements. PROPOSED COMMERCIAL APPLICATION: An innovative ultrasonic desktop device and process to rapidly and automatically liquefy solid drug dosage forms at the point of use will be a commercially viable product with medical and economic benefits. The device will provide a significant improvement in the delivery of nursing care to a large, specialized patient population. The improved medication delivery process will benefit nursing practice, improved medication related outcomes, decrease incidental hospitalization costs, and provide a platform from which best practice can be defined.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

37 SBIR/STTR records share this UEI (1995–2025). Reported award amounts total $17,195,648. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Defense, Department of Health and Human Services, Department of Education, National Aeronautics and Space Administration

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.